Expression of tumor cell markers and PD-L1 on primary patient-derived cells Expression of tumor cell markers and PD-L1 on primary patient-derived cells Expression of tumor cell markers and PD-L1 on primary patient-derived cells Expression of tumor cell markers and PD-L1 on [...] NTRC Oncolines2020-07-17T14:10:18+02:00Cancer Immunotherapy, Combination therapy, Conference, News, News on Homepage, Oncology, Ovarian, Primary material| Read More
